CTIM-03. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT

Authors: Lorenzo Argao, Ying Yuan, Kathleen Wall, Tricia Kunst, Claudia Chambers, Elizabeth Vera, Caitlin Huguely, Masashi Watanabe, Ewa Grajkowska, Zied Abdullaev, Alvina Acquaye-Mallory, Kenneth Aldape, Brita Anderson, Lisa Boris, Daniela A Bota, Nicole Briceno, Eric Burton, Anna Choi, P J Cimino, Pierre Giglio, Carlos Kamiya-Matsuoka, Priya U Kumthekar, Jason Levine, Scott M Lindhorst, Byram Ozer, Marissa Panzer, Tina Pillai, Lily Polskin, Drew Pratt, Martha Quezado, Renee Tweneboah-Koduah, Jing Wu, Terri S Armstrong, Mark R Gilbert, Marta Penas-Prado

Published: 2024-11-11

DOI: 10.1093/neuonc/noae165.0337

Source: Full article


Abstract

Abstract